Arthrex
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Arthrex sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).
Arthrex: 12 sponsored US clinical trials, 5 recruiting.
Arthrex sponsors 12 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Fixation of Osteotomies for Hallux Valgus Treatment (Scarf and Chevron), with 1 trials.
Top-decile sponsor footprint
Arthrex ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
12 total, page 1 of 1
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears
NCT05981833
Knee Related Subchondral Bone Lesions Treated With IOBP
NCT05314608
Registry of Arthrex Hand and Wrist Products
NCT05046600
Evaluate the Continued Safety and Performance of the Foot and Ankle Products
NCT04715139
Total Shoulder Arthroplasty Multi-Center Registry
NCT03511586
Nanoscope Cost Analysis Study
NCT06603740
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
NCT05765266
Study Comparing Steel Wire to a Flat, Braided Suture to Close the Breastbone
NCT04743895
Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)
NCT02713542
Effectiveness Of The Fibulock Intramedullary Nail
NCT02688296
Arthrex Eclipse™ Shoulder Prosthesis
NCT01790113
Web Based Orthopaedic Sports Medicine Registry
NCT01191151
Therapeutic Areas
What is open in the Arthrex pipeline
5 recruiting of 12 indexed (42% open); 4 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Fixation of Osteotomies for Hallux Valgus Treatment (Scarf and Chevron) (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Arthrex: open-pipeline peers nationwide
Peers matched on 12 registered trials and 42% open enrollment, not the therapeutic-area sidebar.
Arthrex sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 12 trials (± recruiting share)
- Alachua Government Services · 12 trials · 0% recruiting
- Allergy Therapeutics · 12 trials · 0% recruiting
- Ampio Pharmaceuticals. · 12 trials · 0% recruiting
- Angiodynamics · 12 trials · 17% recruiting
Sponsors near 42% open enrollment (± trial volume)
- Diwakar Davar · 42% recruiting · 12 trials
- Exactech · 42% recruiting · 12 trials
- Inari Medical · 42% recruiting · 12 trials
- Massachusetts Institute of Technology · 42% recruiting · 24 trials
Related
What to do with this Arthrex page
12 registered trials is a research-attention snapshot, not an endorsement of Arthrex or any single study.
- 5 of Arthrex's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Fixation of Osteotomies for Hallux Valgus Treatment (Scarf and Chevron) is the condition Arthrex studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fixation of Osteotomies for Hallux Valgus Treatment (Scarf and Chevron) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Arthrex pipeline card: 12 registered trials from official public datasets.Report a data error.